Home » Newsletters » BioWorld Science

BioWorld Science

June 18, 2012

View Archived Issues

Multiple insulin degludec trials presented at recent conferences

Canadian study links gene's copy number to ankylosing spondylitis

New model allows assessment of two islet preparations in one primate

Novel apoptosis inducers created at IMPACT Therapeutics

First-in-human data presented on oncolytic BAY-1000394

Simcere presents new calcium channel blockers/acetylcholinesterase inhibitors

Eli Lilly designs novel metabotropic glutamate receptor antagonists

Sunovion reports Canadian approval of once-daily schizophrenia therapy

Anergis achieves preclinical milestones

Civitas Therapeutics advances inhaled levodopa formulation to phase IIa

Sublingual drug for sleep disorders approved in Europe

AstraZeneca and Dainippon Sumitomo jointly patent new oncolytics

New tau-detecting diagnostics developed by GE Healthcare and Medi-Physics

Portola updates on trial of universal factor Xa inhibitor antidote

Phase II study tests iron chelator in adults with transfusional iron overload

EPFL reports novel antibacterials

Dyax discontinues trial of drug for ACE inhibitor-induced angioedema

Wilex oral uPA inhibitor is efficacious in proof-of-concept study

Lysogene advances gene therapy study in Sanfilippo type A syndrome

Janssen files applications to extend Zytiga indication

Debiopharm and Ascepion enter license agreement for multikinase inhibitor

Bavarian Nordic receives government contract for MVA-BN-based vaccines

Valeant Pharmaceuticals to acquire oral health product company

Tosedostat studied for elderly patients with AML or high-risk MDS

First clinical data disclosed on Bristol-Myers Squibb drug for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...